The antiserum was produced against synthesized peptide derived from human MAX around the phosphorylation site of Ser2. AA range:1-50

Phospho-Max (S2) Polyclonal Antibody detects endogenous levels of Max protein only when phosphorylated at S2.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):MsDND

MAX BHLHD4

Protein max

MAX ;
BHLHD4 ;
Protein max ;
Class D basic helix-loop-helix protein 4 ;
bHLHd4 ;
Myc-associated factor X

The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members , which include Mad , Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation , differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Mutations of this gene have been reported to be associated with hereditary pheochromocytoma. A pseudogene of this gene is located on the long arm of chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq , Aug 2012] ,

Alternative products:Additional isoforms seem to exist ,Caution:The sequence shown here is derived from an Ensembl automatic analysis pipeline and should be considered as preliminary data. ,Function:Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5'-CAC[GA]TG-3'. The MYC-MAX complex is a transcriptional activator , whereas the MAD-MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3-K9 histone methyltransferase activity. ,PTM:Reversible lysine acetylation might regulate the nuclear-cytoplasmic shuttling of specific Max complexes. ,similarity:Contains 1 basic helix-loop-helix (bHLH) domain. ,subunit:Efficient DNA binding requires dimerization with another bHLH protein. Binds DNA as a heterodimer with MYC or MAD. Part of the E2F6.com-1 complex in G0 phase composed of E2F6 , MGA , MAX , TFDP1 , CBX3 , BAT8 , EUHMTASE1 , RING1 , RNF2 , MBLR , L3MBTL2 and YAF2. Interacts with SPAG9. ,tissue specificity:High levels found in the brain , heart and lung while lower levels are seen in the liver , kidney and skeletal muscle. ,

Nucleus. Cell projection , dendrite .

>>MAPK signaling pathway ;
>>Pathways in cancer ;
>>Transcriptional misregulation in cancer ;
>>Small cell lung cancer